BREAKING
Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 hour ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 3 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 5 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 7 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 8 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 9 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 9 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 12 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 12 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 13 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 hour ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 3 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 5 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 7 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 8 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 9 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 9 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 12 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 12 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 13 hours ago
ADVERTISEMENT
Analysis

SmileDirectClub stock hits its lowest since IPO amid analyst initiations

SmileDirectClub (NASDAQ: SDC) stock has fallen 32% to $11.20 on Tuesday, which is the teledentistry company’s lowest since the initial public offering on September 12. Investors remained concerned about the company’s growth prospects despite the “buy” equivalent-rating given by all of the ten banks that led its IPO. The firms believed an outstanding and robust […]

October 8, 2019 2 min read

SmileDirectClub (NASDAQ: SDC) stock has fallen 32% to $11.20 on Tuesday, which is the teledentistry company’s lowest since the initial public offering on September 12. Investors remained concerned about the company’s growth prospects despite the “buy” equivalent-rating given by all of the ten banks that led its IPO.

The firms believed an outstanding and robust future for the teeth-straightening startup. The company is expected to turn beneficial in the future driven by the convenience and ease of access over the traditional orthodontics business model. The company’s new business model has grown rapidly backed by the demand for the product, despite facing significant challenges from regulators and potential competitors.

However, the company has been struggling to manage the complaints filed against it in the last five years. The complaints raised questions about its practice of medicine and the lives of patients while the dental boards in Georgia and Alabama have deemed certain of its practices as illegal.

SmileDirectClub stock hits lowest since IPO
Courtesy: SmileDirectClub / Facebook post

The company has incurred net operating losses since inception and this is likely to continue in the near future. Till now, significant funds were spent in organizational and start-up activities, to recruit employees, to develop clear aligners, to develop manufacturing and member support resources, and for research and development.

ADVERTISEMENT

The adoption of the teledentistry model by the consumers remained the main of the company. The unwillingness of adoption by the consumers could hurt the company’s future results. However, the company expects sales of its clear aligners to continue to account for the vast majority of its total net revenues for the foreseeable future.

Read: Spotify looks bumpy in the road to growth

The total market of SmileDirectClub is greater than 120 million people in the US and about 500 million people globally, based on total malocclusion prevalence and age and income demographics. The company is in the early stage of penetrating the opportunity of addressing over 90% of the market today.

For the six months ended June 30, 2019, the company reported a 113% jump in revenues as an increase in the number of website visitors and conversion thereof to aligner sales drove unique aligner orders higher. An increase in the costs and expenses specifically of sales and marketing spend hurt the bottom line with the loss expanding wider than the prior-year period.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT
ADVERTISEMENT